Pre-transplant pharmacokinetics as a predictor of the tacrolimus dose requirement post renal transplantation.

Trial Profile

Pre-transplant pharmacokinetics as a predictor of the tacrolimus dose requirement post renal transplantation.

Completed
Phase of Trial: Phase IV

Latest Information Update: 10 Nov 2009

At a glance

  • Drugs Tacrolimus (Primary)
  • Indications Renal transplant rejection
  • Focus Pharmacokinetics
  • Sponsors Janssen-Cilag
  • Most Recent Events

    • 10 Nov 2009 Actual number of patients (89) added as reported by ClinicalTrials.gov.
    • 23 Oct 2007 Status change
    • 02 Dec 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top